423 related articles for article (PubMed ID: 32211413)
21. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
Zhang G; Fan E; Zhong Q; Feng G; Shuai Y; Wu M; Chen Q; Gou X
Hum Genomics; 2019 Aug; 13(1):36. PubMed ID: 31416476
[TBL] [Abstract][Full Text] [Related]
22. An Autophagy-related Long Non-coding RNA Signature for Breast Cancer.
Jiang F; Wu C; Wang M; Wei K; Wang J
Comb Chem High Throughput Screen; 2022; 25(8):1327-1335. PubMed ID: 34082670
[TBL] [Abstract][Full Text] [Related]
23. Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases.
Feng Q; Wang J; Cui N; Liu X; Wang H
Ann Transl Med; 2021 Nov; 9(22):1668. PubMed ID: 34988177
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
Front Oncol; 2020; 10():597569. PubMed ID: 33614483
[TBL] [Abstract][Full Text] [Related]
25. LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer.
Huang R; Zhou L; Chi Y; Wu H; Shi L
Biomark Res; 2020; 8():8. PubMed ID: 32128213
[TBL] [Abstract][Full Text] [Related]
26. A Seven-Autophagy-Related Long Non-Coding RNA Signature Can Accurately Predict the Prognosis of Patients with Renal Cell Carcinoma.
Du R; Xiao Q; Huang J; Feng W; Zheng X; Yi T
Int J Gen Med; 2022; 15():8143-8157. PubMed ID: 36389022
[TBL] [Abstract][Full Text] [Related]
27. Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.
Peng Y; Xu C; Wen J; Zhang Y; Wang M; Liu X; Zhao K; Wang Z; Liu Y; Zhang T
Front Oncol; 2021; 11():704038. PubMed ID: 34458145
[TBL] [Abstract][Full Text] [Related]
28. The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer.
Yuan C; Liu C; Zhao S; Zhang X; Jia H; Chen B; Zhang M; Zheng Y; Zhou J; Bo Y
J Oncol; 2022; 2022():4689396. PubMed ID: 36111241
[TBL] [Abstract][Full Text] [Related]
29. An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients.
Liu Y; Liu B; Jin G; Zhang J; Wang X; Feng Y; Bian Z; Fei B; Yin Y; Huang Z
Front Oncol; 2019; 9():1269. PubMed ID: 31824849
[TBL] [Abstract][Full Text] [Related]
30. Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer.
Tang Q; Hu X; Guo Q; Shi Y; Liu L; Ying G
Front Genet; 2022; 13():704988. PubMed ID: 35664303
[No Abstract] [Full Text] [Related]
31. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Liu N; Liu Z; Liu X; Chen H
Front Oncol; 2019; 9():935. PubMed ID: 31649871
[TBL] [Abstract][Full Text] [Related]
32. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
33. An eight-long noncoding RNA expression signature for colorectal cancer patients' prognosis.
Zhang L; Chen S; Wang B; Su Y; Li S; Liu G; Zhang X
J Cell Biochem; 2019 Apr; 120(4):5636-5643. PubMed ID: 30320902
[TBL] [Abstract][Full Text] [Related]
34. Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer.
Chen ZH; Lin YL; Chen SQ; Yang XY
World J Gastrointest Oncol; 2023 Nov; 15(11):1951-1973. PubMed ID: 38077636
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of a novel prognosis model based on m5C-related long non-coding RNAs in colorectal cancer.
Di Z; Xu G; Ding Z; Li C; Song J; Huang G; Zheng J; Zhang X; Xiong B
Cancer Cell Int; 2023 Sep; 23(1):196. PubMed ID: 37670275
[TBL] [Abstract][Full Text] [Related]
36. [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
Yang FL; Hong K; Zhao GJ; Liu C; Song YM; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):615-622. PubMed ID: 31420610
[TBL] [Abstract][Full Text] [Related]
37. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
38. Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.
Yu X; Zhang Y
Oncol Lett; 2020 Apr; 19(4):2793-2800. PubMed ID: 32218832
[TBL] [Abstract][Full Text] [Related]
39. A seven-lncRNA signature for predicting prognosis in breast carcinoma.
Xu M; Chen Z; Lin B; Zhang S; Qu J
Transl Cancer Res; 2021 Sep; 10(9):4033-4046. PubMed ID: 35116701
[TBL] [Abstract][Full Text] [Related]
40. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
